⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSTV News
PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
globenewswire.com
PSTV
Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™
globenewswire.com
PSTV
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
PSTV
Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
KPRX
Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas
globenewswire.com
PSTV